These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 33116484)
101. Levofloxacin-Loaded Nanosonosensitizer as a Highly Efficient Therapy for Bacillus Calmette-Guérin Infections Based on Bacteria-Specific Labeling and Sonotheranostic Strategy. Li G; Li J; Hou Y; Xie S; Xu J; Yang M; Li D; Du Y Int J Nanomedicine; 2021; 16():6553-6573. PubMed ID: 34602818 [TBL] [Abstract][Full Text] [Related]
102. Pharmacokinetics of HupA-PLGA-NPs of different sizes in the mouse blood and brain determined by LC-MS/MS. Zhang RH; Wang C; Shi T; Chen XJ; Xu JF; Shi M; Li LQ Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1183-1195. PubMed ID: 35253175 [TBL] [Abstract][Full Text] [Related]
103. In vivo Bio-Distribution and Toxicity Evaluation of Polymeric and Lipid-Based Nanoparticles: A Potential Approach for Chronic Diseases Treatment. Fonseca-Gomes J; Loureiro JA; Tanqueiro SR; Mouro FM; Ruivo P; Carvalho T; Sebastião AM; Diógenes MJ; Pereira MC Int J Nanomedicine; 2020; 15():8609-8621. PubMed ID: 33177821 [TBL] [Abstract][Full Text] [Related]
104. Oral Delivery of Bavachinin-Loaded PEG-PLGA Nanoparticles for Asthma Treatment in a Murine Model. Wang K; Feng Y; Li S; Li W; Chen X; Yi R; Zhang H; Hong Z J Biomed Nanotechnol; 2018 Oct; 14(10):1806-1815. PubMed ID: 30041726 [TBL] [Abstract][Full Text] [Related]
105. Polymeric Nanoparticles: A Holistic Approach to Combat Tuberculosis. Rani S; Sharma AK; Kasu R; Gupta U Crit Rev Ther Drug Carrier Syst; 2022; 39(5):83-115. PubMed ID: 35993997 [TBL] [Abstract][Full Text] [Related]
106. Nanosized Drug Delivery Systems to Fight Tuberculosis. Bourguignon T; Godinez-Leon JA; Gref R Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839715 [TBL] [Abstract][Full Text] [Related]
108. Sustained Delivery of Rifampicin Nanoformulation Administration Intravitreally Into Rabbit Eyes for Ocular Tuberculosis. Yadav R; Tiwari C; Kumar V; Pandey A; Kondel R; Shafiq N Cureus; 2024 Jul; 16(7):e65368. PubMed ID: 39184745 [TBL] [Abstract][Full Text] [Related]
109. Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies. Kumar M; Virmani T; Kumar G; Deshmukh R; Sharma A; Duarte S; Brandão P; Fonte P Pharmaceuticals (Basel); 2023 Sep; 16(10):. PubMed ID: 37895831 [TBL] [Abstract][Full Text] [Related]
110. Development of tetracycline-modified nanoparticles for bone-targeted delivery of anti-tubercular drug. Liang Q; Zhang P; Zhang L; Luan H; Li X; Xiang H; Jing S; Song X Front Bioeng Biotechnol; 2023; 11():1207520. PubMed ID: 37635999 [No Abstract] [Full Text] [Related]
111. The Idiosyncratic Efficacy of Spironolactone-Loaded PLGA Nanoparticles Against Murine Intestinal Schistosomiasis. Abd El Hady WE; El-Emam GA; Saleh NE; Hamouda MM; Motawea A Int J Nanomedicine; 2023; 18():987-1005. PubMed ID: 36860210 [TBL] [Abstract][Full Text] [Related]
112. Formulation and Evaluation of Pravastatin Sodium-Loaded PLGA Nanoparticles: In vitro-in vivo Studies Assessment. Elsayed SI; Girgis GNS; El-Dahan MS Int J Nanomedicine; 2023; 18():721-742. PubMed ID: 36816332 [TBL] [Abstract][Full Text] [Related]
113. Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis. Bahlool AZ; Fattah S; O'Sullivan A; Cavanagh B; MacLoughlin R; Keane J; O'Sullivan MP; Cryan SA Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015371 [TBL] [Abstract][Full Text] [Related]
114. Recent advances in PLGA micro/nanoparticle delivery systems as novel therapeutic approach for drug-resistant Shao L; Shen S; Liu H Front Bioeng Biotechnol; 2022; 10():941077. PubMed ID: 35935487 [No Abstract] [Full Text] [Related]
115. Optimization, Characterization and Pharmacokinetic Study of Meso-Tetraphenylporphyrin Metal Complex-Loaded PLGA Nanoparticles. Mollaeva MR; Yabbarov N; Sokol M; Chirkina M; Mollaev MD; Zabolotskii A; Seregina I; Bolshov M; Kaplun A; Nikolskaya E Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830136 [TBL] [Abstract][Full Text] [Related]
116. Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses. Cortés H; Hernández-Parra H; Bernal-Chávez SA; Prado-Audelo MLD; Caballero-Florán IH; Borbolla-Jiménez FV; González-Torres M; Magaña JJ; Leyva-Gómez G Materials (Basel); 2021 Jun; 14(12):. PubMed ID: 34200640 [TBL] [Abstract][Full Text] [Related]
117. Development of Rifapentine-Loaded PLGA-Based Nanoparticles: In vitro Characterisation and in vivo Study in Mice. Liang Q; Xiang H; Li X; Luo C; Ma X; Zhao W; Chen J; Tian Z; Li X; Song X Int J Nanomedicine; 2020; 15():7491-7507. PubMed ID: 33116484 [TBL] [Abstract][Full Text] [Related]
118. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P; Haddadi A Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163 [TBL] [Abstract][Full Text] [Related]
119. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin. Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238 [TBL] [Abstract][Full Text] [Related]